HumanCo Acquisition Corp. (HMCOU) Stock Analysis
DELISTED 2022
What happened to HumanCo Acquisition Corp. (HMCOU) stock?
HumanCo Acquisition Corp. (HMCOU) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
HumanCo Acquisition Corp. (HMCOU) trades at $10.04. HumanCo Acquisition Corp. is a shell company focused on identifying and merging with a business in the health and wellness sector. Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for HMCOU: HMCOU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HMCOU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
HumanCo Acquisition Corp. (HMCOU) Financial Services Profile
HumanCo Acquisition Corp. is a special purpose acquisition company (SPAC) targeting businesses within the health and wellness ecosystem. Incorporated in 2020, the company seeks to identify and merge with a high-growth potential target, offering investors exposure to the evolving consumer health and wellness market.
What Is the Investment Thesis for HMCOU?
HumanCo Acquisition Corp. presents an investment opportunity predicated on its ability to successfully identify and merge with a high-growth company in the health and wellness sector. The company's experienced management team, with a track record in building consumer brands, is a key value driver. A successful merger could lead to significant appreciation in the stock price, driven by the growth potential of the target company. However, the investment is subject to the risk of failing to find a suitable target within the given timeframe, which could result in the liquidation of the SPAC and a return of capital to investors. The P/E ratio is currently 15.10. The timeline for identifying and completing a merger is typically within 24 months of the IPO.
Based on FMP financials and quantitative analysis
HMCOU Key Highlights
HumanCo Acquisition Corp. is a SPAC focused on the health and wellness sector.
- The company's objective is to identify and merge with a target company, enhancing shareholder value.
- HumanCo's management team brings experience in building and scaling consumer-focused brands.
- The company was incorporated in 2020 and is based in Austin, Texas.
- The P/E ratio is 15.10.
Who Are HMCOU's Competitors?
HMCOU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.35 | -5.41% | $1.89B | 66 |
| APXT Apex Technology Acquisition Corp. | $10.12 | -0.05% | $1.89B | 64 |
| APXTU Apex Treasury Corporation | $10.26 | +0.39% | $1.89B | 64 |
| WCHS Winchester Holding Group | $5.01 | +0.00% | $532M | 63 |
| MESH Meshflow Acquisition Corp. | $10.04 | -0.05% | $433M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HMCOU's Key Strengths?
Experienced management team with a track record in building consumer brands.
- Focus on the high-growth health and wellness sector.
- Access to capital through the IPO.
- Flexibility to pursue a variety of transaction structures.
What Are HMCOU's Weaknesses?
Lack of operating history.
- Dependence on identifying and acquiring a suitable target.
- Competition from other SPACs and private equity firms.
- Potential for conflicts of interest between management and shareholders.
What Could Drive HMCOU Stock Higher?
Announcement of a definitive merger agreement with a target company.
- Progress in negotiations with potential target companies.
- Continued growth in the health and wellness sector.
What Are the Key Risks for HMCOU?
Failure to identify and acquire a suitable target within the given timeframe.
- Economic downturn or market volatility impacting the target company's performance.
- Changes in consumer preferences or regulations affecting the health and wellness sector.
- Competition from other SPACs and private equity firms for attractive targets.
What Are the Growth Opportunities for HMCOU?
- Target Company Growth: The primary growth opportunity lies in the potential of the target company that HumanCo acquires. If HumanCo successfully merges with a high-growth company in the health and wellness sector, the combined entity could experience significant revenue and earnings growth. The timeline for realizing this growth depends on the specific target company and its market position.
- Operational Improvements: HumanCo's management team can drive growth by implementing operational improvements within the target company. This could involve streamlining operations, improving marketing and sales strategies, and expanding into new markets. The potential for operational improvements depends on the specific target company and its current state of operations. The timeline for implementing these improvements is typically within the first 12-24 months after the merger.
- Synergies: The merger between HumanCo and its target company could create synergies that drive growth. These synergies could include cost savings, revenue enhancements, and cross-selling opportunities. The potential for synergies depends on the specific target company and its compatibility with HumanCo's existing operations and expertise. The timeline for realizing these synergies is typically within the first 12-36 months after the merger.
- Market Expansion: The combined entity could expand into new geographic markets or product categories, driving growth. This could involve entering new countries, launching new products, or targeting new customer segments. The potential for market expansion depends on the specific target company and its existing market presence. The timeline for market expansion is typically within the first 24-48 months after the merger.
- Brand Building: HumanCo's management team can leverage its experience in building consumer brands to enhance the target company's brand equity and drive growth. This could involve investing in marketing and advertising, improving customer service, and creating a stronger brand identity. The potential for brand building depends on the specific target company and its existing brand recognition. The timeline for brand building is typically a long-term effort, spanning several years.
What Opportunities Does HMCOU Have?
- Growing demand for health and wellness products and services.
- Increasing number of private companies seeking to go public.
- Potential to create synergies through acquisitions.
- Opportunity to build a leading company in the health and wellness sector.
What Are HMCOU's Competitive Advantages?
- HumanCo's moat is primarily based on the experience and reputation of its management team.
- Their expertise in building consumer brands can provide a competitive advantage.
- The ability to identify and secure a high-quality target company is also a key differentiator.
What Does HMCOU Do?
HumanCo Acquisition Corp., incorporated in 2020 and based in Austin, Texas, is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company's primary focus is on identifying and partnering with a business within the health and wellness sector. HumanCo's strategy involves leveraging its management team's experience in building and scaling consumer-focused brands to create value for shareholders. As a special purpose acquisition company (SPAC), HumanCo does not have any operating history or significant operations of its own. Its sole purpose is to raise capital through an initial public offering (IPO) and then use those funds to acquire a target company. The success of HumanCo depends on its ability to identify a suitable target, negotiate favorable terms, and complete the acquisition within a specified timeframe, typically within 24 months of the IPO. The health and wellness sector is a broad and rapidly growing market, encompassing various areas such as healthy foods, fitness, personal care, and wellness services. HumanCo aims to capitalize on this trend by bringing a promising company in this space to the public market.
What Products and Services Does HMCOU Offer?
- HumanCo Acquisition Corp. is a special purpose acquisition company (SPAC).
- The company's sole purpose is to identify and merge with a private company.
- They focus on companies within the health and wellness ecosystem.
- HumanCo raises capital through an initial public offering (IPO).
- They use the IPO proceeds to acquire a target company.
- The goal is to bring a promising private company to the public market.
How Does HMCOU Make Money?
- HumanCo raises capital through an IPO, selling units consisting of shares and warrants.
- The company seeks to acquire a private company in the health and wellness sector.
- If a suitable target is found, HumanCo merges with the target company, taking it public.
- HumanCo's sponsors and management team typically receive equity in the merged company.
What Industry Does HMCOU Operate In?
HumanCo Acquisition Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to go public more quickly and with less regulatory scrutiny than traditional IPOs. The health and wellness sector, which HumanCo targets, is a large and growing market, fueled by increasing consumer awareness of health and wellness issues. The competitive landscape includes other SPACs also seeking targets in the health and wellness space, as well as traditional private equity firms and strategic acquirers.
Who Are HMCOU's Key Customers?
- HumanCo's initial customers are investors who purchase units in its IPO.
- After a merger, the customers become the shareholders of the combined company.
- The target company's customers remain customers of the merged entity.
Company Profile
HumanCo Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Austin, US. HMCOU has traded publicly since 2020.
HMCOU Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that executives believe in the value of their own stock.
- Community sentiment has shifted positively as discussions around potential acquisitions and partnerships have gained traction.
- The company’s focus on health and wellness sectors aligns with growing consumer trends, enhancing its appeal to investors.
- Increased media attention on the SPAC market has led to renewed interest in HumanCo, boosting its visibility among retail investors.
Bear Case
- Concerns over the overall SPAC market's volatility may lead to skepticism among investors regarding the sustainability of any gains.
- Recent bearish sentiment from some community members reflects uncertainty about the company's ability to deliver on its growth promises.
- The lack of concrete updates on potential mergers or acquisitions could lead to frustration among shareholders, impacting confidence.
- Overall market conditions remain uncertain, which could influence investor behavior negatively, especially in less established companies.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HMCOU Latest News
No recent news available for HMCOU.
Classification
Industry Shell CompaniesCommon Questions About HMCOU (Financial Services)
What happened to HumanCo Acquisition Corp. (HMCOU) stock?
HumanCo Acquisition Corp. (HMCOU) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.
Can I still buy HMCOU shares?
No. HMCOU stopped trading on public markets in December 2022, so the shares are not available through a broker. Anything you see quoted for HMCOU elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HMCOU stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to HumanCo Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does HumanCo Acquisition Corp. do?
HumanCo Acquisition Corp. is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed to raise capital through an initial public offering (IPO) with the intention of acquiring or merging with an existing private company. HumanCo focuses specifically on businesses within the health and wellness sector.
What do analysts say about HMCOU stock?
As of 2026-03-17, there is no available analyst coverage or consensus for HumanCo Acquisition Corp. (HMCOU). This is typical for SPACs before they announce a definitive merger agreement with a target company.
What are the main risks for HMCOU?
The primary risk for HumanCo Acquisition Corp. is the failure to identify and acquire a suitable target company within the specified timeframe, which is typically 24 months from the IPO.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The analysis is limited by the lack of information on potential target companies.